Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app guide heart patients back to strength?

NCT ID NCT05989594

Disease control Sponsor: Shanghai Zhongshan Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether a home-based, mobile-guided exercise program can help older adults recover physical function after undergoing transcatheter aortic valve replacement (TAVR), a procedure to replace a narrowed heart valve. Participants will be randomly assigned to either the guided exercise program or routine care, and their walking ability and physical performance will be measured over time. The goal is to see if a structured, app-supported rehabilitation plan can improve recovery and daily functioning compared to standard follow-up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Home-based mobile guided exercise-based cardiac rehabilitation
What this could lead to
If effective, this approach could offer a convenient, app-guided way to boost physical recovery and quality of life after heart valve replacement, potentially reducing hospital readmissions.
What could go wrong
The trial is relatively small and early, and results may not apply to all patients. Adherence to home exercise can vary, and some participants may not improve as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Mar 2024

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 60 years and ≤ 89 years old; * Patients scheduled to be discharged after TAVR; * Those who have the ability to read and write, and have normal speech and communication skills; * Patients and their families are willing to participate in this study; * Patients or family members have the ability to use mobile and an app. Exclusion Criteria: * Serious complications occur before discharge (such as major bleeding, stroke, valve detachment, moderate or above perivalve leakage, coronary artery occlusion, etc.) ; * Patients who are unable to participate in postoperative exercise rehabilitation due to limb dysfunction; * Being in palliative care or treatment; * Those with other Contraindication to exercise-based cardiac rehabilitation (such as resting ECG changes indicating significant ischemia, acute myocardial infarction or other acute cardiac events, unstable angina, uncontrolled arrhythmia, heart failure decompensation, etc.); * Currently participating in other rehabilitation projects.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac rehabilitation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac rehabilitation

Contacts and locations

Locations

  • Zhongshan Hospital, Fudan University

    Shanghai, Shanghaio, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.